Reinhart, K.
Reinhart, Konrad 1947-
Konrad Reinhart
Reinhart, Konrad (Konrad Anton), Anaesthesioloog, 1947-
VIAF ID: 266910835 (Personal)
Permalink: http://viaf.org/viaf/266910835
Preferred Forms
- 100 0 _ ‡a Konrad Reinhart
- 100 1 _ ‡a Reinhart, K.
- 100 1 _ ‡a Reinhart, K.
- 100 1 0 ‡a Reinhart, K.
-
-
- 100 1 _ ‡a Reinhart, Konrad ‡d 1947-
- 100 1 _ ‡a Reinhart, Konrad ‡d 1947-
-
4xx's: Alternate Name Forms (15)
5xx's: Related Names (4)
- 510 2 _ ‡a Freie Universität Berlin ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Integriertes Forschungs- und Behandlungszentrum Sepsis und Sepsisfolgen ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 551 _ _ ‡a Jena ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 510 2 _ ‡a Klinik für Anästhesiologie und Intensivmedizin ‡g Jena ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
Works
Title | Sources |
---|---|
Abstracts / 4th International Congress "Sepsis and Multiorgan Dysfunction" September 9 - 12, 2009, Weimar | |
Abstracts / 7. Deutscher Interdisziplinärer Kongress für Intensivmedizin und Notfallmedizin 1. - 4. Dezember 2004, CCH, Hamburg | |
Abstracts: I. International Jena Symposium | |
Adjuvant selenium supplementation in the form of sodium selenite in postoperative critically ill patients with severe sepsis | |
Adverse effects of delayed antimicrobial treatment and surgical source control in adults with sepsis: results of a planned secondary analysis of a cluster-randomized controlled trial | |
Barriers and supportive conditions to improve quality of care for critically ill patients: A team approach to quality improvement. | |
The burden of sepsis: a call to action in support of World Sepsis Day 2013 | |
Catecholamine and volume therapy for cardiac surgery in Germany--results from a postal survey | |
Challenges in end-of-life care in the ICU: statement of the 5th International Consensus Conference in Critical Care: Brussels, Belgium, April 2003: executive summary | |
Characterization of buccal microvascular response in patients with septic shock. | |
Clinical aspects of O₂-transport and tissue oxygenation | |
Concerns over use of hydroxyethyl starch solutions | |
Crossing the handover chasm: Clinicians' perceptions of barriers to the early detection and timely management of severe sepsis and septic shock | |
Current concepts and perspectives for the monitoring and diagnosis of critically ill patients | |
Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature | |
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial | |
effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study | |
The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock | |
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial | |
"Euthanasia": A confusing term, abused under the Nazi regime and misused in present end-of-life debate | |
Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study. | |
Fever and hypothermia represent two populations of sepsis patients and are associated with outside temperature | |
Genome-wide association study of survival from sepsis due to pneumonia: an observational cohort study | |
Global utilization of low-dose corticosteroids in severe sepsis and septic shock: a report from the PROGRESS registry | |
Has mortality from acute renal failure decreased? A systematic review of the literature | |
Heparin-induced thrombocytopenia type II in a surgical intensive care unit | |
Hydrocortisone therapy for patients with septic shock | |
Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock | |
Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study | |
Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis | |
The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study. | |
Intensive insulin therapy and pentastarch resuscitation in severe sepsis | |
Is albumin administration in the acutely ill associated with increased mortality? Results of the SOAP study | |
The late phase of sepsis is characterized by an increased microbiological burden and death rate | |
Markers of endothelial damage in organ dysfunction and sepsis | |
Moderate-dose vasopressin therapy may impair gastric mucosal perfusion in severe sepsis: a pilot study | |
Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study | |
Nachhaltige Medizin | |
New approaches to sepsis: molecular diagnostics and biomarkers. | |
A novel questionnaire to measure staff perception of end-of-life decision making in the intensive care unit--development and psychometric testing | |
Organfunktion und Stoffwechsel in der perioperativen Phase | |
The PIRO concept: R is for response | |
Poor outcome is associated with less negative fluid balance in patients with aneurysmal subarachnoid hemorrhage treated with prophylactic vasopressor-induced hypertension | |
Prevention, diagnosis, terapy and follow-up care of sepsis 1st. revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)) | |
Procalcitonin (PCT) as a marker of severe infections and sepsis in critically ill patients | |
Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated). | |
Re: Clinical Trials in Volume Resuscitation with Hydroxyethyl Starch: Focus on Risk of Bias | |
Readmission to a surgical intensive care unit: incidence, outcome and risk factors | |
Relatives' perception of stressors and psychological outcomes - Results from a survey study. | |
S2-Leitlinie Diagnose und Therapie der Sepsis | |
Sepsis an interdisciplinary challenge ; [papers amended from discussions at the 2nd International Steglitz Symposium held in Berlin in Oct. 1987] | |
Sepsis, c1989: | |
Sepsis Current Perspectives in Pathophysiology and Therapy | |
Sepsis e. interdisziplinäre Herausforderung | |
Sepsis und Multiorgandysfunktion [13. - 16. Februar 2001, Abstraktband] | |
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 | |
Theory and practice in anesthesiology and intensive care medicine | |
To transfuse or not to transfuse: thinking outside the box. | |
Transcription in response to physical stress--clues to the molecular mechanisms of exercise-induced asthma | |
A Transcriptomic Biomarker to Quantify Systemic Inflammation in Sepsis - A Prospective Multicenter Phase II Diagnostic Study | |
Understanding the Harms of HES: A Review of the Evidence to Date | |
use of mid-regional proadrenomedullin to identify disease severity and treatment response to sepsis - a secondary analysis of a large randomised controlled trial | |
Validation study of German inpatient administrative health data for epidemiological surveillance and measurement of quality of care for sepsis: the OPTIMISE study protocol | |
The Validity of Advance Directives in Acute Situations | |
Venous oximetry | |
Zur Frage halbseitiger Sympathikus-Defizitsymptome nach ischämischen Grosshirninsulten | |
Zur Kombination von Periduralanalgesie und Allgemeinanaesthesie beim Risikopatienten Auswirkungen der Sympathikusblockade auf Hämodynamik und Sauerstoffverbrauch |